CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 


Biogen Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biogen Inc's ROI in the fourth quarter of 2023?
Biogen Inc achieved a return on average invested assets (ROI) of 5.16 % in its fourth quarter of 2023, which is below Biogen Inc's average return on investment, which stands at 16.15%.

ROI fell compared to the third quarter of 2023, despite the net income growth of % from the third quarter of 2023.

Within the Healthcare sector 97 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2023 quarter, so far to 971, from total ROI ranking in the third quarter of 2023 at 1095.

Definition and Formula of Return on Investment


Return On Investment (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Investment Change 10.05 % 10.74 % 9.52 % 9.81 % -
Y / Y Net Income Change -54.7 % - -43.96 % 77.39 % -
Investment (TTM) in Millions 23,411 23,167 21,964 21,574 21,272
Return On Investment (TTM) 5.16 % 6.65 % 12.44 % 14.94 % 14.47 %
BIIB's Overall Ranking # 971 # 1095 # 44 # 46 # 428
Seq. Investment Change 1.05 % 5.48 % 1.81 % 1.42 % 1.69 %
Seq. Net Income Change - - 53.07 % -29.46 % -51.58 %
Net Income (TTM) in Millions 1,162 1,462 2,665 3,131 2,962




Return On Investment BIIB's Ranking
Within: No.
Industry # 11
Sector # 98
Overall # 971

Return On Investment Statistics
High Average Low
33.77 %
16.15 %
0.45 %
(June 30. 2016)   (June 30. 2006)







Financial Statements
Biogen Inc's IV. Quarter Investments $ 23,411 Millions BIIB's Balance sheet
Biogen Inc's IV. Quarter Income $ 249 Millions Quarterly BIIB's Income Statement
BIIB's Income by Division See BIIB's Income by Division


BIIB Annual Return On Investment (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Investments in Millions 23,411 21,272 19,643 20,863 21,954
Y / Y Investment Growth 10.05 % 8.29 % -5.85 % -4.97 % -0.15 %
Net Income in Millions 1,162 2,962 1,728 4,061 5,889
Y / Y Net Income Growth -60.78 % 71.43 % -57.45 % -31.04 % 31.62 %
Annual Return On Investment 4.96 % 13.92 % 8.8 % 19.46 % 26.82 %


Annual Roi Comment
In the fiscal year 2023 ROI decreased relative to the previous year to 4.96 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIIB's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for BIIB's Competitors
Roi for Biogen Inc's Suppliers
Return On Investment for BIIB's Customers

Other Ratios
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Statistics
BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI
Shockwave Medical Inc   13.81 %
Utah Medical Products Inc  13.61 %
Ufp Technologies Inc   13.08 %
Orasure Technologies Inc  12.68 %
Progyny Inc   12.20 %
Pro dex Inc   12.04 %
Dexcom Inc   12.01 %
Organon and Co   11.96 %
Cadre Holdings Inc   11.72 %
Baxter International Inc   11.56 %
Incyte Corporation  11.52 %
Gilead Sciences Inc   11.46 %
Tactile Systems Technology Inc   11.45 %
Neurocrine Biosciences Inc   11.39 %
Hologic Inc  11.38 %
Hutchmed china Limited  11.36 %
Bristol myers Squibb Company  11.11 %
Align Technology inc   11.02 %
Patterson Companies Inc   10.96 %
Smith and Nephew Plc  10.52 %
Kewaunee Scientific Corporation  10.37 %
Electromed Inc   10.30 %
Option Care Health Inc   10.29 %
Insulet Corporation  10.29 %
Stryker Corp  10.23 %
Lemaitre Vascular Inc   9.92 %
Abbott Laboratories  9.64 %
Nature s Sunshine Products inc   9.48 %
Amgen Inc   9.25 %
Fonar Corporation  9.20 %


Date modified: 2024-02-16T23:53:59+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com